Retatrutide may have an edge for visceral fat reduction given the glucagon component effects on liver fat metabolism
Moein can address these concerns as part of your comprehensive care plan
Losing weight, gaining market share The lawsuit is just the latest punch thrown in an ongoing fight between the two behemoths that dominate the lucrative weight loss medication industry
The lawsuits allege that the drug, which mimics the GLP-1 hormone in the body that aids in insulin secretion, causes severe side effects, including gastroparesis and pancreatic cancer
While ok in the short term, long term, significant nutrient, protein and calorie intake puts you at higher risk of certain conditions, including bone loss (osteoporosis), a compromised immune system, hair loss, compromised cell health, nutrient deficiencies, weakness & fatigue, hormonal imbalances, cognitive impairment and sleep disturbances
It specifically attacks the fat that drives metabolic disease